SELUTION DeNovo Trial – the largest randomized Drug Eluting Balloon trial – demonstrates a SELUTION SLR™ DEB strategy is non-inferior to a Drug Eluting Stent treatment strategy in de novo lesions. SELUTION4ISR, a randomized controlled trial, proves SELUTION SLR™ DEB is an alternative to…

12-month data from pivotal randomized studies underscore Cordis’ commitment to shaping the future of cardiovascular care. MIAMI LAKES, Fla., Oct. 21, 2025 /PRNewswire/ — Cordis, a global leader in interventional cardiovascular technologies, will share late-breaking 12-month results from…